Clinicopathological characteristics of desmoplastic ameloblastoma: A systematic review. Issue 1 (14th July 2017)

• Record Type: Journal Article
• Authors: Anand, Rahul; Sarode, Gargi S.; Sarode, Sachin C.; Reddy, Mamatha; Unadkat, Hemant V.; Mushtaq, Shazia; Deshmukh, Revati; Choudhary, Shakira; Gupta, Nitin; Ganjre, Anjali P.; Patil, Shankargouda
• Is Part Of: Journal of investigative and clinical dentistry. Volume 9:Issue 1(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-07-14
• Subjects: ameloblastoma -- desmoplastic ameloblastoma -- jaw tumor -- odontogenic tumors -- systematic review; Dentistry -- Periodicals; Mouth -- Diseases -- Periodicals; Mouth Diseases -- Periodicals; Tooth Diseases -- Periodicals; 617.6
• DOI: 10.1111/jicd.12282
• Languages: English
• ISSNs: 2041-1618

Abstract

Abstract: The aim of the present review was to systematically present the clinicopathological data of desmoplastic ameloblastoma (DA) from articles published in the literature. A comprehensive search of the databases (PubMed, Medline, SCOPUS, Web of Science, and Google Scholar) for published articles on DA was conducted. A total of 238 cases were identified and analyzed from 76 published papers. DA showed a slight male predilection (male: female=1.07:1) with a predominance in the fourth and fifth decades of life. Mandibular involvement (52.55%) was most commonly seen with a marked tendency for the anterior region (mandible: 40.9%, maxilla: 48.07%). The size of the lesion ranged from .5 cm to 20.4 cm, with the majority of cases measuring more than 3 cm in size (53.84%). Radiologically, most of the lesions presented mixed radiolucency and radiopacity (62%), and root resorption was observed in only seven cases. The majority of the lesions showed ill‐defined margins upon radiographic examination (65.78%). Most of the cases were treated with resection (78.57%), and five of the 10 recurrent cases were treated by enucleation/curettage. DA is characterized by the unique presentation of clinicopathological parameters. It is not possible to comment on its aggressive/recurrent nature and best treatment modality due to inadequate follow‐up data.